Malaysia in the Middle: Tackling Hep C in an Unfair World
By Angus Stewart
September 9, 2021
How the Drugs for Neglected Diseases Initiative worked successfully with local and global partners to improve left-behind lives in Southeast Asia
1 min read
False
Advertisement
Search Results
1-10 of 100 results for “红塔红土信息产业精选股票发起式c 基金持仓”
A Roadmap to Improved Drug Access in the Global South
By Greg S Garrett, Jean-Michel Piedagnel
December 6, 2021
We developed a safe and affordable hepatitis C antiviral to save lives in South-East Asia and beyond. One key to success? Alliance management.
1 min read
A Reliable Cold Chain is a Health Equity Issue
By Kuntal Baveja
April 21, 2026
Why temperature-controlled logistics is a critical but overlooked foundation of equitable access to medicines
4 min read
What Price Glory?
By Ann Hayes
April 25, 2016
The pharmaceutical industry receives its fair share of both praise and scorn. Behind the politics, the hard work and impressive achievements of legions of industry researchers often go unnoticed.
1 min read
C&G Therapy? That’ll Do NICEly
By James Strachan
March 19, 2019
The striking combination of remarkable, long-lasting, clinical effectiveness and a hefty price tag presents a real challenge to health technology assessors considering cell and gene therapies...
0 min read
The Advocate
By Maryam Mahdi
October 28, 2019
Sitting Down With… Charles Gore, Executive Director, Medicines Patent Pool (MPP), Geneva, Switzerland.
0 min read
Celebrating the Small Molecule Space: Download Our eBook
March 11, 2022
Our eBook features drug development stories, a drive for novel excipients, new technologies, and more
1 min read
Diabetes and DFMO the Wonder Drug
By Jamie Irvine
February 20, 2024
Researchers repurpose α-difluoromethylornithine as oral medication for type 1 diabetes
2 min read
Business-in-Brief
By Stephanie Vine
November 14, 2018
A new gene therapy, a procurement process gone wrong, and backing away from a biosimilar… What’s new for pharma in business?
0 min read
New Decade, New Hope
By Stephanie Vine
January 21, 2020
Cures for all presents a real focus for the next decade – but companies must be rewarded for their work
0 min read
Browse by Topics
Interviews
Cell & Gene
Bioprocessing
Drug Delivery
Drug Discovery
Development & Clinical
Formulation
Facilities & Equipment
Outsourcing
Packaging
Regulation & Standards
Small Molecules
Supply Chain
Industry News
Research News
Sitting Down With
Innovation Awards
Business & Trends
Technology & Manufacturing
Biopharma
Future of Pharma
Latest
Blogs